Noninvasive Measurement of Cardiac Output in Pulmonary Hypertension Using Inert Gas Rebreathing
NCT ID: NCT01606839
Last Updated: 2014-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34 participants
OBSERVATIONAL
2012-02-29
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Assessment of Pulmonary Artery Pressure
NCT02223559
Non-invasive Diagnosis of Pulmonary Hypertension by Impedance Cardiography
NCT03876509
Evaluation of Non-invasive Continuous Hemodynamic Measurement From Task Force CORE
NCT06007196
Respiratory Monitoring During Right Heart
NCT03061669
Comparison of Different Cardiac Output Measurement Methods in Patients Undergoing Right Heart Catheterization
NCT05665218
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
As the gold standard measurement of CO is performed invasively, there is an urgent need for the development of non-invasive tools like IGR.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who undergo right heart catheterization
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig Boltzmann Gesellschaft
OTHER
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Horst Olschewski, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Graz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ludwig Boltzmann Institute for Lung Vascular Research
Graz, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-079 ex 11/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.